<table border="0" cellpadding="4" id="inv-33423751-4066-4b21-bfc5-43aa905181e2" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 16. Mean Pharmacokinetic Parameters in Pediatric Patients With Epilepsy</caption>
<col span="1" width="30%"></col>
<col span="1" width="17.5%"></col>
<col span="1" width="17.5%"></col>
<col span="1" width="17.5%"></col>
<col span="1" width="17.5%"></col>
<tbody>
<tr>
<td>Pediatric Study Population </td>
<td>Number of <br/>Subjects </td>
<td>T<sub>max</sub>  (hr) </td>
<td>t<sub>½</sub>  (hr) </td>
<td>C1/F <br/>(mL/min/kg) </td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 10 months-5.3 years</content>
</td>
<td>  </td>
<td>  </td>
<td>  </td>
<td>  </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<linkhtml href="#footnote-11">*</linkhtml>
</td>
<td>10 </td>
<td>3.0 <br/>(1.0<content stylecode="bold">-</content> 5.9) </td>
<td>7.7 <br/>(5.7<content stylecode="bold">-</content> 11.4) </td>
<td>3.62 <br/>(2.44<content stylecode="bold">-</content> 5.28) </td>
</tr>
<tr>
<td>Patients taking AEDs with no known effect on the apparent clearance of Lamotrigine </td>
<td>7 </td>
<td>5.2 <br/>(2.9<content stylecode="bold">-</content> 6.1) </td>
<td>19.0 <br/>(12.9<content stylecode="bold">-</content> 27.1) </td>
<td>1.2 <br/>(0.75<content stylecode="bold">-</content> 2.42) </td>
</tr>
<tr>
<td>Patients taking valproate only </td>
<td>8 </td>
<td>2.9 <br/>(1.0<content stylecode="bold">-</content> 6.0) </td>
<td>44.9 <br/>(29.5<content stylecode="bold">-</content> 52.5) </td>
<td>0.47 <br/>(0.23<content stylecode="bold">-</content> 0.77) </td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 5-11 years</content>
</td>
<td>  </td>
<td>  </td>
<td>  </td>
<td>  </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref>
</td>
<td>7 </td>
<td>1.6 <br/>(1.0<content stylecode="bold">-</content> 3.0) </td>
<td>7.0 <br/>(3.8<content stylecode="bold">-</content> 9.8) </td>
<td>2.54 <br/>(1.35<content stylecode="bold">-</content> 5.58) </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref>   plus valproate </td>
<td>8 </td>
<td>3.3 <br/>(1.0<content stylecode="bold">-</content> 6.4) </td>
<td>19.1 <br/>(7.0<content stylecode="bold">-</content> 31.2) </td>
<td>0.89 <br/>(0.39<content stylecode="bold">-</content> 1.93) </td>
</tr>
<tr>
<td>Patients taking valproate only<linkhtml href="#footnote-12">†</linkhtml>
</td>
<td>3 </td>
<td>4.5 (3.0<content stylecode="bold">-</content> 6.0) </td>
<td>65.8 (50.7<content stylecode="bold">-</content> 73.7) </td>
<td>0.24 (0.21<content stylecode="bold">-</content> 0.26) </td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 13-18 years</content>
</td>
<td>  </td>
<td>  </td>
<td>  </td>
<td>  </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref>
</td>
<td>11 </td>
<td>
<linkhtml href="#footnote-13">‡</linkhtml>
</td>
<td>
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td>1.3 </td>
</tr>
<tr>
<td>Patients taking carbamazpine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref>   plus valproate </td>
<td>8 </td>
<td>
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td>
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td>0.5 </td>
</tr>
<tr>
<td>Patients taking valproate only </td>
<td>4 </td>
<td>
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td>
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td>0.3 </td>
</tr>
<tr>
<td>
<br/>
</td>
</tr>
</tbody>
</table>